Eva L. Feldman

Eva L. Feldman

University of Michigan

H-index: 123

North America-United States

Professor Information

University

University of Michigan

Position

Professor

Citations(all)

61738

Citations(since 2020)

24702

Cited By

45242

hIndex(all)

123

hIndex(since 2020)

75

i10Index(all)

460

i10Index(since 2020)

322

Email

University Profile Page

University of Michigan

Research & Interests List

neurology

diabetes

neuropathy

ALS

Alzheimer's disease

Top articles of Eva L. Feldman

Peripheral Immune Profiles Predict ALS Progression in an Age-and Sex-Dependent Manner

Background and ObjectivesAmyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease whose pathobiology associates with peripheral blood immune cell levels and activation patterns in an age and sex-dependent manner. This study's objective was to identify immune profile associations with ALS progression, whether the associations are age and sex-specific, and whether immune profiles can predict a future disease course.MethodsFlow cytometry immune profiles (a combination of 22 peripheral blood immune markers) were generated for 241 participants with ALS and linked to ALS progression, using progression-free survival, which is a composite combining the revised ALS Functional Rating Scale and survival. Participants were first grouped by immune profiles using unsupervised hierarchical clustering, and clusters were associated with subsequent progression-free survival. Next, individual …

Authors

Benjamin J Murdock,Bangyao Zhao,Kristen D Pawlowski,Joshua P Famie,Caroline E Piecuch,Ian F Webber-Davis,Samuel J Teener,Eva L Feldman,Lili Zhao,Stephen A Goutman

Journal

Neurology: Neuroimmunology & Neuroinflammation

Published Date

2024/4/16

Gender Differences in Faculty Perceptions of Mentorship and Sponsorship

Despite increasing awareness of the importance of mentorship and sponsorship in academic medicine and gender differences in their receipt during early career stages, knowledge is lacking regarding the experiences and perceptions of senior faculty. 1-3 We surveyed a national cohort of midto senior-career faculty about their experiences with receiving and providing mentorship and sponsorship and their perceptions regarding the costs and benefits of these relationships.

Authors

Christina M Cutter,Kent A Griffith,Isis H Settles,Abigail J Stewart,Eve A Kerr,Eva L Feldman,Reshma Jagsi

Journal

JAMA Network Open

Published Date

2024/2/5

Professional Experiences and Career Trajectories of Mid-to Senior-Career Women Clinician-Scientists: A Qualitative Study

ImportanceDespite increasing evidence and recognition of persistent gender disparities in academic medicine, qualitative data detailing the association of gender-based experiences with career progression remain sparse, particularly at the mid- to senior-career stage.ObjectiveTo investigate the role gender has played in everyday professional experiences of mid- to senior-career women clinician-scientists and their perceptions of gender-related barriers experienced across their careers.Design, Setting, and ParticipantsIn this qualitative study, a total of 60 of 159 invited clinician-scientists who received National Institutes of Health K08 or K23 awards between 2006 and 2009 and responded to a survey in 2021 agreed to participate. Invitees were selected using random, purposive sampling to support sample heterogeneity. Semistructured in-depth interviews were conducted January to May 2022. For this study …

Authors

Lauren A Szczygiel,Amanda K Greene,Christina M Cutter,Rochelle D Jones,Eva L Feldman,Kelly C Paradis,Isis H Settles,Kanakadurga Singer,Nancy D Spector,Abigail J Stewart,Peter A Ubel,Reshma Jagsi

Journal

JAMA Network Open

Published Date

2024/4/1

Neuropathic Pain With and Without Diabetic Peripheral Neuropathy in Type 1 Diabetes

OBJECTIVE Diabetic peripheral neuropathy (DPN) is common; however, the features and burden of neuropathic pain (NP) in type 1 diabetes (T1D) are poorly understood. We evaluated the incidence of first occurrence, annual prevalence, remission, and risk factors for NP during long-term follow-up of participants with T1D. RESEARCH DESIGN AND METHODS The Michigan Neuropathy Screening Instrument (MNSI) was administered annually (1994–2020) for 1,324 participants in the Epidemiology of Diabetes Interventions and Complications (EDIC) study. NP with clinical signs of DPN (NP DPN+) was defined according to self-reported NP plus an examination score >2, while NP without clinical signs of DPN (NP DPN−) was defined according to self-reported NP and an examination score ≤2. RESULTS At EDIC year 1, median age for participants was 36 …

Authors

Barbara H Braffett,Laure El Ghormli,James W Albers,Eva L Feldman,William H Herman,Rose A Gubitosi-Klug,Catherine L Martin,Trevor J Orchard,Neil H White,John M Lachin,Bruce A Perkins,Rodica Pop-Busui,DCCT/EDIC Research Group

Journal

Diabetes Care

Published Date

2024/2/1

Residential exposure associations with ALS risk, survival, and phenotype: a Michigan-based case-control study

Background: Environmental exposures impact amyotrophic lateral sclerosis (ALS) risk and progression, a fatal and progressive neurodegenerative disease. Better characterization of these exposures is needed to decrease disease burden. Objective: To identify exposures in the residential setting that associate with ALS risk, survival, and onset segment. Methods: ALS and control participants recruited from University of Michigan completed a survey that ascertained exposure risks in the residential setting. ALS risk was assessed using logistic regression models followed by latent profile analysis to consider exposure profiles. A case-only analysis considered the contribution of the residential exposure variables via a Cox proportional hazards model for survival outcomes and multinomial logistic regression for onset segment, a polytomous outcome. Results: This study included 367 ALS and 255 control participants …

Authors

Stephen A Goutman,Jonathan Boss,Dae Gyu Jang,Caroline Piecuch,Hasan Farid,Madeleine Batra,Bhramar Mukherjee,Eva L Feldman,Stuart A Batterman

Journal

Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Published Date

2024/4/1

Gut microbiome correlates with plasma lipids in amyotrophic lateral sclerosis

Amyotrophic lateral sclerosis (ALS) is a complex, fatal neurodegenerative disease. Disease pathophysiology is incompletely understood but evidence suggests gut dysbiosis occurs in ALS, linked to impaired gastrointestinal integrity, immune system dysregulation and altered metabolism. Gut microbiome and plasma metabolome have been separately investigated in ALS, but little is known about gut microbe-plasma metabolite correlations, which could identify robust disease biomarkers and potentially shed mechanistic insight. Here, gut microbiome changes were longitudinally profiled in ALS and correlated to plasma metabolome. Gut microbial structure at the phylum level differed in ALS versus control participants, with differential abundance of several distinct genera. Unsupervised clustering of microbe and metabolite levels identified modules, which differed significantly in ALS versus control participants …

Authors

Kai Guo,Claudia Figueroa-Romero,Mohamed H Noureldein,Benjamin J Murdock,Masha G Savelieff,Junguk Hur,Stephen A Goutman,Eva L Feldman

Journal

Brain

Published Date

2024/2

Environmental risk scores of persistent organic pollutants associate with higher ALS risk and shorter survival in a new Michigan case/control cohort

BackgroundAmyotrophic lateral sclerosis (ALS) is a fatal, progressive neurogenerative disease caused by combined genetic susceptibilities and environmental exposures. Identifying and validating these exposures are of paramount importance to modify disease risk. We previously reported that persistent organic pollutants (POPs) associate with ALS risk and survival and aimed to replicate these findings in a new cohort.MethodParticipants with and without ALS recruited in Michigan provided plasma samples for POPs analysis by isotope dilution with triple quadrupole mass spectrometry. ORs for risk models and hazard ratios for survival models were calculated for individual POPs. POP mixtures were represented by environmental risk scores (ERS), a summation of total exposures, to evaluate the association with risk (ERSrisk) and survival (ERSsurvival).ResultsSamples from 164 ALS and 105 control participants …

Authors

Stephen A Goutman,Jonathan Boss,Dae-Gyu Jang,Bhramar Mukherjee,Rudy J Richardson,Stuart Batterman,Eva L Feldman

Journal

Journal of Neurology, Neurosurgery & Psychiatry

Published Date

2024/3/1

Transcriptomic profiling of sciatic nerves and dorsal root ganglia reveals site-specific effects of prediabetic neuropathy

Peripheral neuropathy (PN) is a severe and frequent complication of obesity, prediabetes, and type 2 diabetes characterized by progressive distal-to-proximal peripheral nerve degeneration. However, a comprehensive understanding of the mechanisms underlying PN, and whether these mechanisms change during PN progression, is currently lacking. Here, gene expression data were obtained from distal (sciatic nerve; SCN) and proximal (dorsal root ganglia; DRG) injury sites of a high-fat diet (HFD)-induced mouse model of obesity/prediabetes at early and late disease stages. Self-organizing map and differentially expressed gene analyses followed by pathway enrichment analysis identified genes and pathways altered across disease stage and injury site. Pathways related to immune response, inflammation, and glucose and lipid metabolism were consistently dysregulated with HFD-induced PN, irrespective of …

Authors

Stéphanie A Eid,Sarah E Elzinga,Kai Guo,Lucy M Hinder,John M Hayes,Crystal M Pacut,Emily J Koubek,Junguk Hur,Eva L Feldman

Journal

Translational Research

Published Date

2024/8/1

Professor FAQs

What is Eva L. Feldman's h-index at University of Michigan?

The h-index of Eva L. Feldman has been 75 since 2020 and 123 in total.

What are Eva L. Feldman's research interests?

The research interests of Eva L. Feldman are: neurology, diabetes, neuropathy, ALS, Alzheimer's disease

What is Eva L. Feldman's total number of citations?

Eva L. Feldman has 61,738 citations in total.

What are the co-authors of Eva L. Feldman?

The co-authors of Eva L. Feldman are Brian Callaghan, Nicholas Boulis, Stephen A Goutman.

Co-Authors

H-index: 49
Brian Callaghan

Brian Callaghan

University of Michigan-Dearborn

H-index: 49
Nicholas Boulis

Nicholas Boulis

Emory University

H-index: 30
Stephen A Goutman

Stephen A Goutman

University of Michigan-Dearborn

academic-engine

Useful Links